Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$12.65
-0.42-3.21%
At close: -
$12.65
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Viridian Therapeutics Stock Price, Quotes and Forecasts
VRDNNASDAQ
Viridian Therapeutics (VRDN) Forecast
NewsEarningsViridian Therapeutics (VRDN) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Viridian Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:VRDN | Benzinga
Explore Viridian Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for VRDN.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Viridian Therapeutics (VRDN) stock?
You can purchase shares of Viridian Therapeutics (NASDAQ:VRDN) through any online brokerage.
Who are Viridian Therapeutics (VRDN) competitors?
Other companies in Viridian Therapeutics’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Syndax Pharmaceuticals (NASDAQ:SNDX) and CareDx (NASDAQ:CDNA).
What is the forecast, or price target, for Viridian Therapeutics (VRDN) stock?
Viridian Therapeutics has a consensus price target of $38.73.
What is the current price for Viridian Therapeutics (VRDN)?
The stock price for Viridian Therapeutics (NASDAQ: VRDN) is $12.65 last updated April 3, 2025 at 4:00 PM EDT.
Does Viridian Therapeutics (VRDN) pay a dividend?
There are no upcoming dividends for Viridian Therapeutics.
When is Viridian Therapeutics (NASDAQ:VRDN) reporting earnings?
Viridian Therapeutics’s Q1 earnings are confirmed for Wednesday, May 7, 2025.
Is Viridian Therapeutics (VRDN) going to split?
There is no upcoming split for Viridian Therapeutics.
What sector and industry does Viridian Therapeutics (VRDN) operate in?
Viridian Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.